Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings
The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on a...
Saved in:
Published in | Psychological medicine Vol. 39; no. 11; pp. 1763 - 1777 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Cambridge, UK
Cambridge University Press
01.11.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 0033-2917 1469-8978 1469-8978 |
DOI | 10.1017/S0033291709005315 |
Cover
Loading…
Abstract | The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type?
A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed.
Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal.
Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. |
---|---|
AbstractList | The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type?BACKGROUNDThe potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type?A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed.METHODA systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed.Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal.RESULTSThirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal.Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders.CONCLUSIONSAntipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. Background. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? Method. A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Results. Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Conclusions. Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. Adapted from the source document. Background: The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review addresses two issues: (1) do antipsychotic medications induce changes in total or regional human brain volumes and (2) do such effects depend on antipsychotic type? Method: A systematic review of studies reporting structural brain magnetic resonance imaging (MRI) measures: (1) directly in association with antipsychotic use; and (2) in patients receiving lifetime treatment with antipsychotics in comparison with drug-naive patients or healthy controls. We searched Medline and EMBASE databases using the medical subject heading terms: 'antipsychotics' AND 'brain' AND (MRI NOT functional). The search included studies published up to 31 January 2007. Wherever possible, we reported the effect size of the difference observed. Results: Thirty-three studies met our inclusion criteria. The results suggest that antipsychotics act regionally rather than globally on the brain. These volumetric changes are of a greater magnitude in association with typical than with atypical antipsychotic use. Indeed, there is evidence of a specific effect of antipsychotic type on the basal ganglia, with typicals specifically increasing the volume of these structures. Differential effects of antipsychotic type may also be present on the thalamus and the cortex, but data on these and other brain areas are more equivocal. Conclusions: Antipsychotic treatment potentially contributes to the brain structural changes observed in psychosis. Future research should take into account these potential effects, and use adequate sample sizes, to allow improved interpretation of neuroimaging findings in these disorders. [PUBLICATION ABSTRACT] |
Author | Dazzan, P. Navari, S. |
Author_xml | – sequence: 1 givenname: S. surname: Navari fullname: Navari, S. email: serena.navari@iop.kcl.ac.uk organization: 1Division of Psychological Medicine and Psychiatry, Institute of Psychiatry, King's College London, UK – sequence: 2 givenname: P. surname: Dazzan fullname: Dazzan, P. organization: 1Division of Psychological Medicine and Psychiatry, Institute of Psychiatry, King's College London, UK |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21990770$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19338710$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkkFv1DAQhS1URLeFH8AFWUjAKeCx4zg-oaq0pVCEoCAQF8uxncUlcRY7Afbf42iXViqinGxpvjejeW_20E4YgkPoPpCnQEA8OyeEMSpBEEkIZ8BvoQWUlSxqKeodtJjLxVzfRXspXRACDEp6B-2CZKwWQBZIvRiwDqNfpbX5OozeYBunZcK6bZ0ZcRO1DziNcTLjFN1zfIDTOo2u1zOqg8Um-vzVHY7uh3c_8dDiN-9PceuD9WGZ7qLbre6Su7d999HH46MPhy-Ls7cnp4cHZ4XhlRiLGrhmoiaUggPKrKOCsBZkzVhrTVMb6nhlqeGltLxyoqYNlNo2phbWGm3ZPnqy6buKw_fJpVH1PhnXdTq4YUpKsJIIWlcyk49vJLlgAJVg_wUpMEZKPoMPr4EXwxRDXldRUpaSAxUZerCFpqZ3Vq2i73Vcqz9RZODRFtAp-9lGHYxPlxwFKYkQMwcbzsQhpejaq1ZEzWeh_jqLrBHXNMaPOcIhjDng7kZlsVH6nPqvy1E6flPZI8FVdfJOnX_5zMTr6pX6lHm2naT7Jnq7dFdm_HvKb_vT1sM |
CODEN | PSMDCO |
CitedBy_id | crossref_primary_10_1016_j_neubiorev_2010_11_004 crossref_primary_10_3389_fpsyt_2022_802025 crossref_primary_10_1016_j_ajp_2016_10_031 crossref_primary_10_1016_j_euroneuro_2016_09_371 crossref_primary_10_1016_j_pscychresns_2011_08_011 crossref_primary_10_1017_S0033291710001686 crossref_primary_10_1016_j_schres_2011_08_021 crossref_primary_10_1111_acps_12440 crossref_primary_10_3389_fnhum_2016_00373 crossref_primary_10_1016_j_euroneuro_2012_09_001 crossref_primary_10_1016_j_pscychresns_2010_06_006 crossref_primary_10_1038_tp_2012_116 crossref_primary_10_1016_j_neubiorev_2013_01_003 crossref_primary_10_1016_j_neubiorev_2014_03_014 crossref_primary_10_1111_acps_12677 crossref_primary_10_1016_j_cortex_2012_08_027 crossref_primary_10_1016_j_nicl_2019_101959 crossref_primary_10_1016_j_bpsc_2019_10_014 crossref_primary_10_1111_j_1600_0447_2010_01632_x crossref_primary_10_1016_j_jpsychires_2012_05_008 crossref_primary_10_1111_j_1600_0447_2012_01868_x crossref_primary_10_1016_j_nicl_2017_11_004 crossref_primary_10_1590_1516_4446_2013_1120 crossref_primary_10_1016_j_schres_2010_10_004 crossref_primary_10_1017_S1461145710000817 crossref_primary_10_1017_S003329171100119X crossref_primary_10_1016_j_jad_2018_11_082 crossref_primary_10_1016_j_neubiorev_2017_09_023 crossref_primary_10_1016_j_jpsychires_2013_03_010 crossref_primary_10_1017_S0033291721004098 crossref_primary_10_1016_j_schres_2013_12_015 crossref_primary_10_1177_0004867416631827 crossref_primary_10_1093_schbul_sbp151 crossref_primary_10_1016_j_biopsych_2014_05_023 crossref_primary_10_2217_npy_12_13 crossref_primary_10_1007_s12021_013_9184_3 crossref_primary_10_1016_j_schres_2013_04_029 crossref_primary_10_1017_S0033291712000098 crossref_primary_10_3389_fpsyt_2018_00217 crossref_primary_10_1016_j_pscychresns_2017_01_008 crossref_primary_10_1017_S0033291722002896 crossref_primary_10_1097_JCP_0b013e31820e3f58 crossref_primary_10_1016_j_biopsych_2015_02_008 crossref_primary_10_1111_jcpp_12307 crossref_primary_10_1016_j_eurpsy_2015_02_009 crossref_primary_10_1038_tp_2016_238 crossref_primary_10_1177_2040622320905215 crossref_primary_10_1016_j_neulet_2021_136065 crossref_primary_10_1016_j_pnpbp_2021_110251 crossref_primary_10_1111_sjop_12414 crossref_primary_10_1016_j_pscychresns_2014_11_004 crossref_primary_10_1017_S0033291710001698 crossref_primary_10_1017_S0033291717000642 crossref_primary_10_1007_s11682_018_9935_8 crossref_primary_10_1017_S0033291711002716 crossref_primary_10_1016_j_mri_2013_08_004 crossref_primary_10_1007_s10548_013_0288_8 crossref_primary_10_1017_S0033291711002157 crossref_primary_10_1016_j_schres_2015_01_021 crossref_primary_10_1016_j_schres_2016_03_039 crossref_primary_10_1016_j_pscychresns_2020_111067 crossref_primary_10_1016_j_bbr_2013_05_061 crossref_primary_10_1093_brain_awaa025 crossref_primary_10_1093_schbul_sby189 crossref_primary_10_1111_chso_12049 crossref_primary_10_1093_schbul_sbs083 crossref_primary_10_1177_02698811221087645 crossref_primary_10_1016_j_neubiorev_2016_10_004 crossref_primary_10_1016_j_neuroimage_2025_121127 crossref_primary_10_1007_s00406_016_0747_9 crossref_primary_10_1176_appi_ajp_2015_14091108 crossref_primary_10_1523_JNEUROSCI_6056_11_2012 crossref_primary_10_1186_1471_244X_13_342 crossref_primary_10_1016_j_schres_2011_07_018 crossref_primary_10_1016_j_comppsych_2018_11_014 crossref_primary_10_1016_j_nicl_2013_12_007 crossref_primary_10_1016_j_schres_2017_08_061 crossref_primary_10_1148_radiol_2016152149 crossref_primary_10_1038_npp_2016_64 crossref_primary_10_1017_S0033291710002205 crossref_primary_10_1016_j_pscychresns_2017_09_010 crossref_primary_10_1177_070674371405901003 crossref_primary_10_1177_02841851231179174 crossref_primary_10_1016_j_euroneuro_2012_08_008 crossref_primary_10_1017_S0033291713001001 crossref_primary_10_1126_scisignal_2004331 crossref_primary_10_1016_j_seizure_2022_09_006 crossref_primary_10_1007_s11920_012_0345_0 crossref_primary_10_1016_j_pscychresns_2012_09_013 crossref_primary_10_1016_j_pnpbp_2011_03_014 crossref_primary_10_1016_j_schres_2009_09_011 crossref_primary_10_3109_15622975_2014_984629 crossref_primary_10_1016_j_neuroscience_2015_07_039 crossref_primary_10_1007_s11682_017_9681_3 crossref_primary_10_1016_j_euroneuro_2011_06_004 crossref_primary_10_1016_j_pscychresns_2017_11_004 crossref_primary_10_1016_j_biopsych_2012_04_020 crossref_primary_10_1016_j_schres_2017_07_014 crossref_primary_10_1093_schbul_sbaa011 crossref_primary_10_3389_fgene_2019_00519 crossref_primary_10_1016_j_psychres_2021_113962 crossref_primary_10_1016_j_cortex_2012_01_009 crossref_primary_10_1016_j_neuroimage_2018_04_054 crossref_primary_10_1038_s41433_021_01580_4 crossref_primary_10_1016_j_tics_2015_09_009 crossref_primary_10_31887_DCNS_2014_16_4_pdazzan crossref_primary_10_1016_j_schres_2010_09_008 crossref_primary_10_1016_j_eurpsy_2013_10_006 crossref_primary_10_1016_j_jaac_2016_01_004 crossref_primary_10_1038_tp_2015_195 crossref_primary_10_1371_journal_pone_0231669 crossref_primary_10_1016_j_schres_2024_01_031 crossref_primary_10_1002_hbm_25093 crossref_primary_10_1016_j_biopsych_2018_04_023 crossref_primary_10_1002_hbm_23906 crossref_primary_10_1007_s00115_014_4027_5 crossref_primary_10_1093_schbul_sbs152 crossref_primary_10_1016_j_pscychresns_2010_12_009 crossref_primary_10_1080_10508422_2014_880920 crossref_primary_10_1016_j_schres_2015_09_014 crossref_primary_10_1371_journal_pone_0166651 crossref_primary_10_1017_S003329171300319X crossref_primary_10_1586_ern_11_76 crossref_primary_10_1007_s00429_018_1634_0 crossref_primary_10_1177_2045125317752915 crossref_primary_10_1017_S003329171300024X crossref_primary_10_1038_npp_2015_90 crossref_primary_10_1007_s00406_015_0650_9 crossref_primary_10_1016_j_neuroimage_2011_05_058 crossref_primary_10_1016_j_schres_2024_05_002 crossref_primary_10_1016_j_pscychresns_2012_05_001 crossref_primary_10_1093_schbul_sbz119 crossref_primary_10_1016_j_schres_2015_09_027 crossref_primary_10_1038_s41598_019_42532_z crossref_primary_10_3390_jcm10184131 crossref_primary_10_1038_s41598_017_10688_1 crossref_primary_10_1016_j_ajp_2024_104167 crossref_primary_10_1017_S003329170900573X crossref_primary_10_1017_S0033291709992297 crossref_primary_10_1517_14656566_2016_1114101 crossref_primary_10_1192_bjp_bp_116_182683 crossref_primary_10_1016_j_biopsych_2017_08_011 crossref_primary_10_1016_j_schres_2016_12_008 crossref_primary_10_1016_j_pscychresns_2011_06_008 crossref_primary_10_1016_j_pscychresns_2019_06_003 crossref_primary_10_1016_j_pscychresns_2018_08_015 crossref_primary_10_1016_j_npbr_2014_01_001 crossref_primary_10_1080_17522439_2011_577588 crossref_primary_10_1186_2194_7511_1_3 crossref_primary_10_1016_j_schres_2010_08_016 crossref_primary_10_1093_schbul_sbs135 crossref_primary_10_1016_j_brainres_2015_10_002 crossref_primary_10_1007_s11682_017_9729_4 crossref_primary_10_1017_S0033291713000238 crossref_primary_10_1016_j_psychres_2024_116261 crossref_primary_10_1016_j_schres_2013_06_025 crossref_primary_10_1016_j_pscychresns_2014_12_004 crossref_primary_10_1016_j_schres_2016_01_025 crossref_primary_10_1038_s41598_019_43955_4 crossref_primary_10_1038_s41398_020_00940_0 crossref_primary_10_1016_j_euroneuro_2014_07_015 crossref_primary_10_1590_1516_4446_2014_1387 crossref_primary_10_1007_s11682_014_9313_0 crossref_primary_10_1016_j_schres_2015_06_016 crossref_primary_10_1097_WNN_0000000000000380 crossref_primary_10_1016_j_euroneuro_2016_11_002 crossref_primary_10_1016_j_pscychresns_2013_10_002 crossref_primary_10_1111_j_1399_5618_2012_01023_x crossref_primary_10_1016_j_schres_2014_12_022 crossref_primary_10_1111_j_1528_1167_2012_03504_x crossref_primary_10_1007_s00429_010_0280_y crossref_primary_10_1016_j_pscychresns_2012_04_014 crossref_primary_10_1177_20451253231195258 crossref_primary_10_1016_j_biopsych_2010_11_010 crossref_primary_10_1016_j_jad_2015_01_018 crossref_primary_10_1016_j_nicl_2016_06_002 crossref_primary_10_1017_S1092852912000739 crossref_primary_10_1016_j_neubiorev_2013_06_001 crossref_primary_10_1017_S0033291721003809 crossref_primary_10_1038_s41398_020_01049_0 crossref_primary_10_1016_j_biopsych_2011_05_017 crossref_primary_10_1016_j_schres_2020_02_005 crossref_primary_10_3389_fpsyt_2014_00116 crossref_primary_10_1016_j_schres_2009_05_028 crossref_primary_10_1016_j_schres_2013_10_009 crossref_primary_10_1093_schbul_sbs118 crossref_primary_10_1017_S0033291710002163 crossref_primary_10_1016_j_pscychresns_2012_04_002 crossref_primary_10_1002_hup_2574 crossref_primary_10_1093_schbul_sbaf002 crossref_primary_10_1016_j_schres_2012_07_014 crossref_primary_10_1016_j_biopsych_2022_07_017 crossref_primary_10_1017_S1461145711000794 crossref_primary_10_1016_j_biopsych_2010_03_019 crossref_primary_10_1038_s41398_021_01475_8 crossref_primary_10_1186_s40345_018_0124_x crossref_primary_10_1016_j_ijdevneu_2018_12_004 crossref_primary_10_1016_j_schres_2013_03_002 crossref_primary_10_1155_2014_325052 crossref_primary_10_1016_j_jad_2020_11_064 crossref_primary_10_1016_j_tins_2014_12_005 crossref_primary_10_1016_j_neubiorev_2011_12_015 crossref_primary_10_1017_S1092852920001546 crossref_primary_10_1007_s00234_010_0830_2 crossref_primary_10_1038_s41537_022_00230_2 crossref_primary_10_1007_s11682_020_00284_9 crossref_primary_10_1016_j_pscychresns_2013_09_010 crossref_primary_10_1016_j_neubiorev_2013_10_004 crossref_primary_10_1016_j_schres_2014_11_006 crossref_primary_10_1016_j_neubiorev_2020_10_021 crossref_primary_10_1016_j_neubiorev_2014_12_016 crossref_primary_10_1001_jamapsychiatry_2022_2075 crossref_primary_10_1002_hbm_22075 crossref_primary_10_1016_j_bpsc_2019_01_002 crossref_primary_10_1111_joa_14180 crossref_primary_10_1016_j_nicl_2016_09_006 crossref_primary_10_1093_schbul_sbv173 crossref_primary_10_1016_j_pscychresns_2011_05_005 crossref_primary_10_1016_j_biopsych_2010_12_012 crossref_primary_10_1038_npp_2015_22 crossref_primary_10_1517_13543784_2011_601738 crossref_primary_10_1080_17522430903501999 crossref_primary_10_1017_S0033291711000341 crossref_primary_10_1176_appi_psychotherapy_2016_70_1_5 crossref_primary_10_1177_0004867417699473 crossref_primary_10_1017_S095457941900035X crossref_primary_10_1093_cercor_bhv255 crossref_primary_10_1007_s12640_010_9178_y crossref_primary_10_1111_j_1468_1331_2010_03321_x crossref_primary_10_1016_j_psychres_2023_115345 crossref_primary_10_1016_j_schres_2009_06_022 crossref_primary_10_1186_s12952_015_0030_z crossref_primary_10_1007_s40263_016_0331_x crossref_primary_10_1017_S0033291709006060 crossref_primary_10_1016_j_pscychresns_2016_01_010 crossref_primary_10_1016_j_schres_2015_02_023 crossref_primary_10_1089_brain_2017_0519 crossref_primary_10_1017_S1355617711001081 crossref_primary_10_1016_j_pscychresns_2025_111968 crossref_primary_10_1038_s41380_019_0355_y crossref_primary_10_1038_mp_2015_209 crossref_primary_10_1007_s00429_014_0706_z crossref_primary_10_1016_j_jad_2020_07_118 crossref_primary_10_1016_j_pscychresns_2018_10_002 crossref_primary_10_1016_j_jpsychires_2012_01_015 crossref_primary_10_1002_hbm_21436 crossref_primary_10_1038_tp_2016_281 |
Cites_doi | 10.1016/S0920-9964(97)00126-6 10.1016/j.biopsych.2005.03.043 10.1523/JNEUROSCI.23-03-00994.2003 10.1001/archpsyc.57.8.761 10.1001/archpsyc.59.11.1002 10.1016/j.pscychresns.2005.06.004 10.1176/ajp.153.4.564 10.1176/ajp.161.10.1829 10.1016/S0006-3223(96)00110-2 10.1176/appi.ajp.162.10.1984-a 10.1016/j.biopsych.2005.02.008 10.1016/S0920-9964(01)00406-6 10.1001/archpsyc.58.2.148 10.1176/ajp.151.10.1430 10.1007/s00213-005-2199-1 10.1038/sj.npp.1300449 10.1176/appi.ajp.158.4.625 10.1001/archpsyc.55.3.235 10.1016/S0140-6736(03)12323-9 10.1016/j.euroneuro.2004.11.005 10.1016/j.pscychresns.2006.04.008 10.1097/01.yco.0000214339.06507.d8 10.1523/JNEUROSCI.18-20-08236.1998 10.1001/archpsyc.62.4.361 10.1001/archpsyc.56.2.133 10.1016/S0920-9964(01)00163-3 10.1001/archpsyc.60.6.585 10.1016/j.schres.2005.10.019 10.1038/sj.npp.1300422 10.1016/S0893-133X(00)00172-X 10.1192/bjp.172.2.110 10.1016/S0893-133X(97)00042-0 10.1176/ajp.156.6.869 10.1017/S1461145704004262 10.1016/j.pscychresns.2003.08.002 10.1073/pnas.201243998 10.1016/S0006-8993(97)01551-5 10.1016/j.schres.2003.08.008 10.1097/01.jcp.0000155818.29091.53 10.1016/S0006-3223(99)00018-9 10.1177/070674370204700106 10.1038/sj.mp.4000581 10.1176/ajp.156.8.1200 10.1001/archpsyc.59.6.553 10.1016/S0006-3223(99)00079-7 10.1176/appi.ajp.158.4.644 10.1016/S0006-3223(00)01001-5 10.1016/S0006-3223(01)01067-8 10.1176/ajp.2006.163.11.2005 10.1097/00001756-200409150-00022 10.1126/science.2867601 10.1016/S0920-9964(01)00330-9 10.1016/S0006-3223(00)01059-3 10.1016/S0140-6736(94)90599-1 10.1093/schbul/sbm168 10.1016/S0140-6736(95)90441-7 10.1038/sj.npp.1300710 10.1016/j.pnpbp.2005.08.019 10.1017/S1121189X00008137 10.1016/S0925-4927(01)00072-5 10.1038/sj.npp.1300603 10.1176/ajp.155.12.1711 10.1001/archpsyc.55.2.145 10.1192/bjp.186.1.26 |
ContentType | Journal Article |
Copyright | Copyright © Cambridge University Press 2009 2009 INIST-CNRS |
Copyright_xml | – notice: Copyright © Cambridge University Press 2009 – notice: 2009 INIST-CNRS |
DBID | BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 0-V 3V. 7QJ 7QP 7QR 7RV 7TK 7X7 7XB 88E 88G 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA ALSLI AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH HEHIP K9. KB0 M0S M1P M2M M2O M2S MBDVC NAPCQ P64 PHGZM PHGZT PJZUB PKEHL POGQB PPXIY PQEST PQQKQ PQUKI PRINS PRQQA PSYQQ Q9U 7X8 |
DOI | 10.1017/S0033291709005315 |
DatabaseName | Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Social Sciences Premium Collection【Remote access available】 ProQuest Central (Corporate) Applied Social Sciences Index & Abstracts (ASSIA) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Nursing & Allied Health Database Neurosciences Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Psychology Database (Alumni) Technology Research Database ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest Central UK/Ireland Social Science Premium Collection ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library Sociology Collection (OCUL) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection PML(ProQuest Medical Library) Psychology Database ProQuest Research Library Sociology Database (OCUL) Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest Sociology & Social Sciences Collection ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest One Social Sciences ProQuest One Psychology ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Psychology Research Library Prep ProQuest Central Student ProQuest Central Essentials Sociology & Social Sciences Collection ProQuest Central China Health Research Premium Collection Health & Medical Research Collection Chemoreception Abstracts ProQuest Central (New) ProQuest Sociology ProQuest Medical Library (Alumni) Social Science Premium Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Sociology Collection Health Research Premium Collection (Alumni) Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Social Sciences Premium Collection ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) Applied Social Sciences Index and Abstracts (ASSIA) ProQuest Central Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Research Library ProQuest Sociology Collection ProQuest One Social Sciences ProQuest Central Basic ProQuest Nursing & Allied Health Source ProQuest Psychology Journals (Alumni) ProQuest Medical Library ProQuest Psychology Journals ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE Neurosciences Abstracts Applied Social Sciences Index and Abstracts (ASSIA) ProQuest One Psychology |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
DocumentTitleAlternate | S. Navari and P. Dazzan Systematic review of antipsychotics and brain structure |
EISSN | 1469-8978 |
EndPage | 1777 |
ExternalDocumentID | 1878121101 19338710 21990770 10_1017_S0033291709005315 ark_67375_6GQ_SZX37K6J_W |
Genre | Systematic Review Journal Article Comparative Study |
GroupedDBID | --- -1D -1F -2P -2V -E. -~6 -~N .FH .GJ .XZ 0-V 08P 09C 09E 0E1 0R~ 123 29P 3V. 4.4 41~ 53G 5RE 5VS 6~7 74X 74Y 7RV 7X7 7~V 88E 8FI 8FJ 8G5 8R4 8R5 9M5 AAAZR AABES AABWE AACJH AAGFV AAKTX AAMNQ AARAB AASVR AATMM AAUIS AAUKB AAWTL AAYEP ABBXD ABBZL ABGDZ ABITZ ABIVO ABJNI ABKKG ABLJU ABQTM ABQWD ABROB ABTCQ ABUWG ABVFV ABVKB ABVZP ABWCF ABXAU ABZCX ABZUI ACBMC ACDLN ACETC ACGFO ACGFS ACHQT ACIMK ACIWK ACPRK ACRPL ACUIJ ACYZP ACZBM ACZUX ADAZD ADBBV ADDNB ADFEC ADFRT ADKIL ADNMO ADOVH ADOVT ADVJH AEBAK AEBPU AEHGV AEMFK AEMTW AENCP AENEX AENGE AEPLO AEYHU AEYYC AFFNX AFFUJ AFKQG AFKRA AFLOS AFLVW AFUTZ AFZFC AGABE AGJUD AGLWM AHIPN AHLTW AHMBA AHQXX AHRGI AIGNW AIHIV AIOIP AISIE AJ7 AJCYY AJPFC AJQAS AKZCZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALSLI ALVPG ANPSP AQJOH ARABE ARALO ARZZG ASOEW ATUCA AUXHV AYIQA AZGZS AZQEC BBLKV BCGOX BENPR BESQT BGHMG BJBOZ BKEYQ BLZWO BMAJL BPHCQ BQFHP BRIRG BVXVI C0O C45 CAG CBIIA CCPQU CCQAD CCUQV CDIZJ CFAFE CFBFF CGQII CHEAL CJCSC COF CS3 DC4 DOHLZ DU5 DWQXO EBS EGQIC EJD EX3 F5P FA8 FYUFA GNUQQ GUQSH HEHIP HG- HMCUK HST HZ~ H~9 I.6 I.7 I.9 IH6 IOEEP IOO IS6 I~P J36 J38 J3A J5H JHPGK JQKCU JVRFK KAFGG KCGVB KFECR L7B L98 LHUNA LW7 M-V M1P M2M M2O M2S M7~ M8. N4W NAPCQ NEJ NIKVX NMFBF NZEOI O9- OMB OMC OMH OVD OYBOY P2P PQQKQ PROAC PSQYO PSYQQ Q2X RCA RIG ROL RR0 S6- S6U SAAAG SY4 T9M TEORI UAP UCJ UKHRP UT1 UU6 VVN WFFJZ WH7 WOW WQ3 WXU WYP YOC YZZ ZCA ZDLDU ZGI ZJOSE ZMEZD ZXP ZYDXJ ~V1 AAFWJ AAKNA ABXHF ACEJA ADPDF AGQPQ AKMAY ANOYL BSCLL IPYYG PHGZM PHGZT PJZUB POGQB PPXIY PRQQA PUEGO AAYXX ABHFL ACOZI CITATION AGKLZ IQODW CGR CUY CVF ECM EIF NPM 7QJ 7QP 7QR 7TK 7XB 8FD 8FK FR3 K9. MBDVC P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c567t-815a3780221e123de2703f19833fdcb8c2e56d2c549d56e782b14adbc87ddcad3 |
IEDL.DBID | 7X7 |
ISSN | 0033-2917 1469-8978 |
IngestDate | Fri Jul 11 09:00:36 EDT 2025 Fri Jul 11 12:02:37 EDT 2025 Fri Jul 11 15:37:52 EDT 2025 Fri Jul 25 04:14:45 EDT 2025 Mon Jul 21 05:55:08 EDT 2025 Mon Mar 31 10:56:58 EDT 2025 Tue Jul 01 02:14:21 EDT 2025 Thu Apr 24 23:01:48 EDT 2025 Sun Aug 31 06:48:18 EDT 2025 Tue Jan 21 06:23:42 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | Antipsychotic drugs brain MRI psychosis Human Volumetric analysis Cerebral cortex Neuroleptic Psychotropic Central nervous system Pharmacotherapy Basal ganglion Review Nuclear magnetic resonance imaging Encephalon Psychosis Treatment Medical imagery Critical study Thalamus Biological effect |
Language | English |
License | https://www.cambridge.org/core/terms CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c567t-815a3780221e123de2703f19833fdcb8c2e56d2c549d56e782b14adbc87ddcad3 |
Notes | ArticleID:00531 PII:S0033291709005315 ark:/67375/6GQ-SZX37K6J-W istex:541847A7BEBAD118197E5D34413B3E2E98713905 ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 ObjectType-Undefined-4 |
PMID | 19338710 |
PQID | 204495127 |
PQPubID | 35753 |
PageCount | 15 |
ParticipantIDs | proquest_miscellaneous_734072869 proquest_miscellaneous_57311673 proquest_miscellaneous_21330453 proquest_journals_204495127 pubmed_primary_19338710 pascalfrancis_primary_21990770 crossref_primary_10_1017_S0033291709005315 crossref_citationtrail_10_1017_S0033291709005315 istex_primary_ark_67375_6GQ_SZX37K6J_W cambridge_journals_10_1017_S0033291709005315 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2009-11-01 |
PublicationDateYYYYMMDD | 2009-11-01 |
PublicationDate_xml | – month: 11 year: 2009 text: 2009-11-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Cambridge, UK |
PublicationPlace_xml | – name: Cambridge, UK – name: Cambridge – name: England |
PublicationTitle | Psychological medicine |
PublicationTitleAlternate | Psychol. Med |
PublicationYear | 2009 |
Publisher | Cambridge University Press |
Publisher_xml | – name: Cambridge University Press |
References | S0033291709005315_ref02a Frazier (S0033291709005315_ref017) 1996; 153 S0033291709005315_ref042 S0033291709005315_ref041 S0033291709005315_ref002 S0033291709005315_ref046 S0033291709005315_ref001 S0033291709005315_ref045 S0033291709005315_ref044 S0033291709005315_ref043 S0033291709005315_ref006 S0033291709005315_ref049 S0033291709005315_ref005 S0033291709005315_ref048 S0033291709005315_ref003 S0033291709005315_ref047 S0033291709005315_ref008 S0033291709005315_ref03a Cohen (S0033291709005315_ref007) 1992; 112 S0033291709005315_ref053 S0033291709005315_ref052 S0033291709005315_ref051 S0033291709005315_ref050 S0033291709005315_ref013 S0033291709005315_ref057 S0033291709005315_ref012 S0033291709005315_ref011 S0033291709005315_ref055 S0033291709005315_ref054 S0033291709005315_ref016 S0033291709005315_ref015 S0033291709005315_ref059 S0033291709005315_ref058 S0033291709005315_ref014 S0033291709005315_ref019 S0033291709005315_ref018 S0033291709005315_ref060 S0033291709005315_ref064 S0033291709005315_ref020 S0033291709005315_ref063 S0033291709005315_ref062 S0033291709005315_ref061 S0033291709005315_ref024 Dazzan (S0033291709005315_ref010) 2005; 30 S0033291709005315_ref023 S0033291709005315_ref022 S0033291709005315_ref065 S0033291709005315_ref021 S0033291709005315_ref028 S0033291709005315_ref027 S0033291709005315_ref026 S0033291709005315_ref025 Chakos (S0033291709005315_ref004) 1994; 151 S0033291709005315_ref029 Corson (S0033291709005315_ref009) 1999; 156 S0033291709005315_ref01a S0033291709005315_ref031 S0033291709005315_ref030 S0033291709005315_ref035 S0033291709005315_ref034 S0033291709005315_ref033 S0033291709005315_ref032 S0033291709005315_ref038 S0033291709005315_ref037 S0033291709005315_ref036 23651623 - Psychol Med. 2013 Jul;43(7):1568. doi: 10.1017/S0033291713001001. 19379533 - Psychol Med. 2009 Nov;39(11):1779-80. doi: 10.1017/S003329170900573X. 19476691 - Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060. |
References_xml | – ident: S0033291709005315_ref065 doi: 10.1016/S0920-9964(97)00126-6 – ident: S0033291709005315_ref01a doi: 10.1016/j.biopsych.2005.03.043 – ident: S0033291709005315_ref059 doi: 10.1523/JNEUROSCI.23-03-00994.2003 – ident: S0033291709005315_ref022 doi: 10.1001/archpsyc.57.8.761 – ident: S0033291709005315_ref002 doi: 10.1001/archpsyc.59.11.1002 – ident: S0033291709005315_ref058 doi: 10.1016/j.pscychresns.2005.06.004 – volume: 153 start-page: 564 year: 1996 ident: S0033291709005315_ref017 article-title: Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment publication-title: American Journal of Psychiatry doi: 10.1176/ajp.153.4.564 – ident: S0033291709005315_ref031 doi: 10.1176/ajp.161.10.1829 – ident: S0033291709005315_ref044 doi: 10.1016/S0006-3223(96)00110-2 – ident: S0033291709005315_ref054 doi: 10.1176/appi.ajp.162.10.1984-a – ident: S0033291709005315_ref019 doi: 10.1016/j.biopsych.2005.02.008 – ident: S0033291709005315_ref057 doi: 10.1016/S0920-9964(01)00406-6 – ident: S0033291709005315_ref036 doi: 10.1001/archpsyc.58.2.148 – volume: 151 start-page: 1430 year: 1994 ident: S0033291709005315_ref004 article-title: Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs publication-title: American Journal of Psychiatry doi: 10.1176/ajp.151.10.1430 – ident: S0033291709005315_ref041 doi: 10.1007/s00213-005-2199-1 – ident: S0033291709005315_ref062 doi: 10.1038/sj.npp.1300449 – ident: S0033291709005315_ref030 doi: 10.1176/appi.ajp.158.4.625 – ident: S0033291709005315_ref03a doi: 10.1001/archpsyc.55.3.235 – ident: S0033291709005315_ref047 doi: 10.1016/S0140-6736(03)12323-9 – ident: S0033291709005315_ref001 doi: 10.1016/j.euroneuro.2004.11.005 – ident: S0033291709005315_ref038 doi: 10.1016/j.pscychresns.2006.04.008 – ident: S0033291709005315_ref052 doi: 10.1097/01.yco.0000214339.06507.d8 – ident: S0033291709005315_ref048 doi: 10.1523/JNEUROSCI.18-20-08236.1998 – ident: S0033291709005315_ref034 doi: 10.1001/archpsyc.62.4.361 – ident: S0033291709005315_ref061 doi: 10.1001/archpsyc.56.2.133 – ident: S0033291709005315_ref055 doi: 10.1016/S0920-9964(01)00163-3 – ident: S0033291709005315_ref026 doi: 10.1001/archpsyc.60.6.585 – ident: S0033291709005315_ref020 doi: 10.1016/j.schres.2005.10.019 – volume: 112 start-page: 115 year: 1992 ident: S0033291709005315_ref007 article-title: A power primer publication-title: Psychiatric Bulletin – ident: S0033291709005315_ref024 doi: 10.1038/sj.npp.1300422 – ident: S0033291709005315_ref050 doi: 10.1016/S0893-133X(00)00172-X – ident: S0033291709005315_ref032 doi: 10.1192/bjp.172.2.110 – ident: S0033291709005315_ref042 doi: 10.1016/S0893-133X(97)00042-0 – ident: S0033291709005315_ref045 doi: 10.1176/ajp.156.6.869 – ident: S0033291709005315_ref046 doi: 10.1017/S1461145704004262 – ident: S0033291709005315_ref006 doi: 10.1016/j.pscychresns.2003.08.002 – ident: S0033291709005315_ref060 doi: 10.1073/pnas.201243998 – ident: S0033291709005315_ref064 doi: 10.1016/S0006-8993(97)01551-5 – ident: S0033291709005315_ref025 doi: 10.1016/j.schres.2003.08.008 – ident: S0033291709005315_ref035 doi: 10.1097/01.jcp.0000155818.29091.53 – ident: S0033291709005315_ref037 doi: 10.1016/S0006-3223(99)00018-9 – ident: S0033291709005315_ref053 doi: 10.1177/070674370204700106 – ident: S0033291709005315_ref015 doi: 10.1038/sj.mp.4000581 – volume: 156 start-page: 1200 year: 1999 ident: S0033291709005315_ref009 article-title: Change in basal ganglia volume over 2 years in patients with schizophrenia: typical versus atypical neuroleptics publication-title: American Journal of Psychiatry doi: 10.1176/ajp.156.8.1200 – ident: S0033291709005315_ref063 doi: 10.1001/archpsyc.59.6.553 – ident: S0033291709005315_ref008 doi: 10.1016/S0006-3223(99)00079-7 – ident: S0033291709005315_ref051 doi: 10.1176/appi.ajp.158.4.644 – ident: S0033291709005315_ref043 doi: 10.1016/S0006-3223(00)01001-5 – ident: S0033291709005315_ref033 doi: 10.1016/S0006-3223(01)01067-8 – ident: S0033291709005315_ref029 doi: 10.1176/ajp.2006.163.11.2005 – ident: S0033291709005315_ref018 doi: 10.1097/00001756-200409150-00022 – ident: S0033291709005315_ref016 doi: 10.1126/science.2867601 – ident: S0033291709005315_ref013 doi: 10.1016/S0920-9964(01)00330-9 – ident: S0033291709005315_ref02a doi: 10.1016/S0006-3223(00)01059-3 – ident: S0033291709005315_ref028 doi: 10.1016/S0140-6736(94)90599-1 – ident: S0033291709005315_ref027 doi: 10.1093/schbul/sbm168 – ident: S0033291709005315_ref003 doi: 10.1016/S0140-6736(95)90441-7 – ident: S0033291709005315_ref014 doi: 10.1038/sj.npp.1300710 – ident: S0033291709005315_ref012 doi: 10.1016/j.pnpbp.2005.08.019 – ident: S0033291709005315_ref011 doi: 10.1017/S1121189X00008137 – ident: S0033291709005315_ref049 doi: 10.1016/S0925-4927(01)00072-5 – volume: 30 start-page: 765 year: 2005 ident: S0033291709005315_ref010 article-title: Different effects of typical and atypical antipsychotics on grey matter in first episode psychosis: the ÆSOP study publication-title: Neuropsychopharmacology doi: 10.1038/sj.npp.1300603 – ident: S0033291709005315_ref023 doi: 10.1176/ajp.155.12.1711 – ident: S0033291709005315_ref021 doi: 10.1001/archpsyc.55.2.145 – ident: S0033291709005315_ref005 doi: 10.1192/bjp.186.1.26 – reference: 23651623 - Psychol Med. 2013 Jul;43(7):1568. doi: 10.1017/S0033291713001001. – reference: 19379533 - Psychol Med. 2009 Nov;39(11):1779-80. doi: 10.1017/S003329170900573X. – reference: 19476691 - Psychol Med. 2009 Nov;39(11):1781-2. doi: 10.1017/S0033291709006060. |
SSID | ssj0013142 |
Score | 2.449611 |
SecondaryResourceType | review_article |
Snippet | The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This review... Background: The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This... Background. The potential effects of antipsychotic drugs on brain structure represent a key factor in understanding neuroanatomical changes in psychosis. This... |
SourceID | proquest pubmed pascalfrancis crossref istex cambridge |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1763 |
SubjectTerms | Anatomy & physiology Antipsychotic Agents - adverse effects Antipsychotic Agents - therapeutic use Antipsychotic drugs Basal Ganglia - drug effects Basal Ganglia - pathology Biological and medical sciences Brain Brain - drug effects Brain - pathology Brain structure Cerebral Cortex - drug effects Cerebral Cortex - pathology Cortex Cross-Sectional Studies Dominance, Cerebral - drug effects Dose-Response Relationship, Drug Drug Administration Schedule Drug therapy Gyrus Cinguli - drug effects Gyrus Cinguli - pathology Humans Longitudinal Studies Magnetic Resonance Imaging Medical imaging Medical sciences Mesencephalon - drug effects MRI Neuropharmacology Neuropsychology Organ Size - drug effects Pharmacology. Drug treatments Psycholeptics: tranquillizer, neuroleptic Psychology. Psychoanalysis. Psychiatry Psychopharmacology Psychoses psychosis Psychotic Disorders - diagnosis Psychotic Disorders - drug therapy Psychotic Disorders - pathology Psychotropic drugs Reference Values Schizophrenia Schizophrenia - diagnosis Schizophrenia - drug therapy Schizophrenia - pathology Subject headings Systematic review Thalamus - drug effects Thalamus - pathology |
Title | Do antipsychotic drugs affect brain structure? A systematic and critical review of MRI findings |
URI | https://www.cambridge.org/core/product/identifier/S0033291709005315/type/journal_article https://api.istex.fr/ark:/67375/6GQ-SZX37K6J-W/fulltext.pdf https://www.ncbi.nlm.nih.gov/pubmed/19338710 https://www.proquest.com/docview/204495127 https://www.proquest.com/docview/21330453 https://www.proquest.com/docview/57311673 https://www.proquest.com/docview/734072869 |
Volume | 39 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELdglRAvCDZgYVD8gPaAiBTH8UeepgIbY6gTDCYqXiJ_ZZqAZDSrBP89Z8dNmVD76txJ8fls3_nufofQC5MzCreISmstwUExuUlLpcs0rwm3UvFaC187PD3lx-fFyYzNYm5OF9Mql2diOKhta_wbOTjpBdjyJBcHV79S3zTKB1djB43baOSRy7zvJWZiFUQgRQ8WHtqVEbEMagbEaBj0Y1kZ1JD9C61w44oaeWn_9imTqgOp1X27i_X2aLiXju6je9GgxJNeAx6gW67ZRjuTBpzpn3_wPg4pnuHtfBvdmcZI-g6q3rYYhHoZq7AuDbbzxUWHVcjvwNp3jsA9uOxi7g7wBK8wn4HRYhN7JOC--AW3NZ6evcchBt5cdA_R-dHhlzfHaWy2kBrGxXUqCVNU-MJb4uA2sy6Hs6AmpaS0tkZLkzvGbW7An7SMOzAsNCmU1UYKa42y9BHaatrG7SJsLZFgWRSSGgUkRtuMaZG7mpeFKWWZoFeDrKu4ZbqqTzcT1X9Lk6BsuRyVicDlvn_Gj00sLweWqx61YxPxfljjgVLNv_t0N8Eq_u5T9fnbjIoP_KT6mqDxDSUYGODULzMhsgTtLbViNa9BcRP0fPgKe9gHZlTj2gWQEP-qxOh6CiaoD5gBBV5DIaiHupMcpPu418fVzEtKwS_Onmz8vT10N0TKQp3lU7QFGuaegcF1rcdhW43R6PXh6cezv6TOJKU |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFRaCbggaHmEQusD9ICIlNhxnBxQtaKU3W63EtCKFZfg2E5V0SZltyvoR_GPjJ3HUqHdW6_JTBR7ZjwznhfAK0U5Qy0i_SJP0EFRVPmpzFOfFmGsExkXubC1w6OjuH8SHYz5eAX-tLUwNq2yPRPdQa0rZe_I0UmP0JYPqdi9_OnboVE2uNpO0Ki5Ymiuf6HHNn032EPyvqZ0_8Px-77fDBXwFY_FlZ-EXDJhC0xDg6e2NhR5vkDXm7FCqzxR1PBYU4V-k-axQQWah5HUuUqE1kpqht-9A2uodwObQSjGYh60CKO6ObkbjxaKNojqOlTjQ_ssSB3b839bOdxQiWuWur9tiqacIpWKerzGYvvX6cH9h_CgMWBJr-a4R7BiynXY6JXovF9ckx3iUkrdXf063B01kfsNyPYqgkQ8a6q-zhTRk9nplEiXT0JyO6mC1M1sZxOzS3pk3mMaETVRzUwGUhfbkKogo88D4mLu5en0MZzcCh2ewGpZleYZEK3DBC2ZKGFKIojKdcBzQU0Rp5FKk9SDt91eZ42ITrM6vU1k_5HGg6AlR6aaRul2Xsf5MpQ3Hcpl3SVkGfCOo3EHKSc_bHqd4Fn88VP25duYiWF8kH31YOsGE3QIqGXSQIjAg82WK-br6gTFg-3uLZ4ZNhAkS1PNECS0t1icLYbggtkAHUKQBRCC2dZ6SYy7-7Tmx_nKU8bQDw-eL_29bbjXPx4dZoeDo-Em3HdROlfj-QJWkdvMSzT2rvItJ2IEvt-2TP8Fg89gDA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFRaqeKCoOURCq0P0AMiUhLHcXJA1Ypl6XbZilfFqpfgV6oKSMpuV9BP4-8YO4-lQru3Xp1xZHtmPDOeF8AzFTGKUkT4hUzRQFGR8jMhMz8qwkSnIikkt7nD4-Pk8CQ-mrDJGvxpc2FsWGV7J7qLWlfKvpGjkR6jLh-ipV40URHv-4ODi5--bSBlHa1tN42aQkbm6hdab7NXwz6i-nkUDd58fn3oNw0GfMUSfumnIROU22TT0OANrk2E9F-gGU5poZVMVWRYoiOFNpRmiUFhKsNYaKlSrrUSmuJ_b8EGp7guZCU-4QsHRhjXhcpdq7SQtw5VV60aB-1YkDkWYP-WdbgmHjcspn_bcE0xQ4wVdauN5bqwk4mDu3CnUWZJr6a-e7Bmyi3Y7pVoyP-4IvvEhZe6d_st2Bw3XvxtyPsVQYSeNxlg54ro6fxsRoSLLSHSdq0gdWHb-dQckB5Z1JvGiZqopj8DqRNvSFWQ8cchcf738mx2H05uBA8PYL2sSvMIiNZhilpNnFIlEERJHTDJI1MkWayyNPPgZXfWecOus7wOdeP5f6jxIGjRkaumaLrt3fF91ZQX3ZSLumLIKuB9h-MOUky_2VA7zvLk7Yf80-mE8lFylH_xYPcaEXQTUOJkAeeBBzstVSz21TGNB3vdV7w_rFNIlKaaI0hoX7QYXQ7BOLXOOoQgSyA4tWX20gRP92FNj4udZ5SiTR48Xrm8PdhEbs7fDY9HO3DbOexcuucTWEdiM09R77uUu47DCHy9aZb-C1QCZEI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Do+antipsychotic+drugs+affect+brain+structure%3F+A+systematic+and+critical+review+of+MRI+findings&rft.jtitle=Psychological+medicine&rft.au=Navari%2C+S&rft.au=Dazzan%2C+P&rft.date=2009-11-01&rft.eissn=1469-8978&rft.volume=39&rft.issue=11&rft.spage=1763&rft_id=info:doi/10.1017%2FS0033291709005315&rft_id=info%3Apmid%2F19338710&rft.externalDocID=19338710 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0033-2917&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0033-2917&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0033-2917&client=summon |